Please complete the CAPTCHA to continue
@sentibio.com
✓
4 phones found area 781, 510, and 650
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Philip Lee is listed as CEO at GeneFab at GeneFab, based in United States. AeroLeads shows a work email signal at sentibio.com, phone signal with area code 781, 510, 650, and a matched LinkedIn profile for Philip Lee.
Philip Lee previously worked as Chief Executive Officer at Genefab and CTO at Senti Biosciences. Philip Lee holds Doctor Of Philosophy (Ph.D.), Bioengineering from University Of California, Berkeley.
This section adds company-level context without repeating Philip Lee's masked contact details.
AeroLeads found 2 current-domain work email signals for Philip Lee. Compare company email patterns before reaching out.
Ph.D. in Bioengineering. Passionate about technology innovation and entrepreneurship in the life science space. Extensive experience commercializing technology platforms-- including microfluidics, cell therapy, research instrumentation, synthetic biology, cell culture systems, and clinical manufacturing. Skilled in science & technology, product development, business strategy, and team management in both startup and corporate environments. 20+ years in the life science research field as a bench scientist, lab director, and executive.
Listed skills include Cell Culture, Biotechnology, Life Sciences, R&D, and 22 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Alameda, California, Us
Founding CEO of GeneFab, a contract research, development, and manufacturing organization (CRDMO) supporting innovative products in the cell and gene therapy field through our expertise in genetic design through cGMP manufacturing.
South San Francisco, Ca, Us
Part of the C-Suite and responsible for technical operations and manufacturing. Leading teams spanning next generation process technology development through ramping and scaling cGMP manufacturing. During my tenure at Senti Bio, I helped raised over $350M of capital and an IPO on NASDAQ (SNTI).
South San Francisco, Ca, Us
Senti Biosciences is developing novel therapeutics to solve challenging and complex diseases. Founded in 2016 and headquartered in the San Francisco Bay Area, Senti leverages expertise in cell engineering and biological programming to build the future of gene and cell based therapies.
South San Francisco, Ca, Us
Co-founder of Senti Biosciences, a leader in leveraging synthetic biology for next generation cell/gene therapies. Played a central role in company formation, fundraising through Seed and Series A, and building the scientific and technical team from scratch.
Darmstadt, De
Managing a team of global product managers covering the life science research market. Responsible for directing franchise strategy, business/marketing decisions, and new product roadmaps & projects.
Burlington, Ma, Us
Business leader in EMD Millipore Molecular & Cell Biology Systems business. Managed early stage innovation projects from conception, prototyping, and product development. Performed market analysis, strategic planning, and technology scouting of external and internal innovation.
Burlington, Ma, Us
Project lead for EMD Millipore Bioscience new technology development. Worked closely with business units and business development teams to formulate and articulate long term innovation vision for the company. Special focus on cell-based technologies including automated cell biology, live-cell analysis, and cell culture systems.
Burlington, Ma, Us
Project lead for EMD Millipore Bioscience new technology development.
Pioneered micro fluidic cell culture systems for biological research. Won multiple NIH and NSF SBIR awards totaling over $4M. Bootstrapped the company to 20 employees and achieving profitability. Won multiple innovation awards including R&D100, The Scientist New Product Award, Lab Automation New Product Award. Acquired by EMD Millipore in 2012.
Worked on micro fluidic cell culture systems for quantitative biology in the lab of Luke Lee at the UC Berkeley Bioengineering department. Received NSF graduate research fellowship, UC Berkeley Center for Entrepreneurship Technology Breakthrough Award, and 3rd place in UC Berkeley business plan competition.
Research as part of the MIT Undergraduate Research Opportunities Program (UROP) in the Langer Lab for biomedical research. Published 3 peer reviewed papers as first author.
Quick answers generated from the profile data available on this page.
Philip Lee works for GeneFab.
Philip Lee is listed as CEO at GeneFab at GeneFab.
AeroLeads has found 2 work email signals at @sentibio.com for Philip Lee at GeneFab.
AeroLeads has found 4 phone signal(s) with area code 781, 510, 650 for Philip Lee at GeneFab.
Philip Lee is based in United States while working with GeneFab.
Philip Lee has worked for Genefab, Senti Biosciences, Merck Kgaa, Darmstadt, Germany, Emd Millipore, and Cellasic.
You can use AeroLeads to view verified contact signals for Philip Lee at GeneFab, including work email, phone, and LinkedIn data when available.
Philip Lee holds Doctor Of Philosophy (Ph.D.), Bioengineering from University Of California, Berkeley.
Philip Lee is listed with skills including Cell Culture, Biotechnology, Life Sciences, R&D, Cell Biology, Product Development, Microfluidics, and Biomedical Engineering.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts